FDA Inspection 1279060 — Laboratorios Liconsa SAU

Laboratorios Liconsa SAU — FEI 3005508367

The FDA completed an inspection of Laboratorios Liconsa SAU on Apr 19, 2023 in Azuqueca De Henares. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 19, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Azuqueca De Henares (Spain)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.